SCHEMBL2082671

SCHEMBL2082671

NC(CO)CNc1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ MAPT P10636 2/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ SPHK1 Q9NYA1 1/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CXCL8 P10145 1/20 0.36
▸ KCNQ2 O43526 1/20 0.36
▸ TAS1R3 Q7RTX0 1/20 0.36
▸ TAS1R1 Q7RTX1 1/20 0.36
▸ HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2082666 1.00 LMNA (0.46) LMNASMN1; SMN2MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL31499025 0.85 LMNA (0.43) LMNASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL11368560 0.75 LMNA (0.56) LMNASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL13446854 0.74 MAPT (0.48) LMNASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL8006423 0.73 LMNA (0.50) LMNASMN1; SMN2MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL31499027 0.72 MEN1 (0.41) LMNASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL11200245 0.72 LMNA (0.45) LMNASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL8011444 0.72 LMNA (0.47) LMNASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL9174930 0.71 LMNA (0.60) LMNASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL11571754 0.71 KDM4E (0.55) LMNASMN1; SMN2MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121641-B1 2-AMINOOXAZOLINES AS TAAR1 LIGANDS HOFFMANN LA ROCHE (CH) 2014-09-24 — — EP disclosed
US-7902238-B2 2-aminooxazolines as TAAR1 ligands HOFFMANN-LA ROCHE INC. (US) 2011-03-08 — — US disclosed
US-20090105307-A1 2-AMINOOXAZOLINES AS TAAR1 LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2009-04-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105307-A1 2-AMINOOXAZOLINES AS TAAR1 LIGANDS TAAR1, TAAR5, NPSR1 LMNA 4812/4885SMN1; SMN2 1284/4885MEN1 1410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback